Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2024

HF remains a major cause of mortality, morbidity, and poor quality of life. Among the most serious manifestations associated with HF is arrhythmia due to the electrophysiological changes within the cardiomyocyte.

Heart Failure 64

Heart Failure Electrophysiology Quality of Life Arrhythmia 64

HeartRhythm

APRIL 30, 2024

Antitachycardia pacing (ATP) has demonstrated a proven benefit in terminating ventricular arrhythmias, reducing shocks and improving quality of life.

Quality of Life 40

Quality of Life Tachycardia Arrhythmia 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 27, 2023

However, ventricular arrhythmias (VA) are common, are mostly secondary to underlying myocardial scar, and have a higher incidence in patients with pre-LVAD VA. Sustained VA is well tolerated in the LVAD patient but can result in implantable defibrillator (ICD) shocks, right ventricular failure, hospitalizations, and reduced quality of life.

Defibrillator 40

Defibrillator Arrhythmia Best Practices Quality of Life 40

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Catheter ablation (CA) has emerged as an important modality for managing AF, improving quality of life, and potentially reversing cardiac dysfunction.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Quality of Life Arrhythmia 40

HeartRhythm

OCTOBER 21, 2024

Sick sinus syndrome (SSS) is a common condition resulting in reduced quality of life, syncope, and pacemaker (PPM) implantation, but predictors have not been elucidated.

Atrial Flutter 40

Atrial Flutter Quality of Life Pacemaker Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Sick sinus syndrome (SSS) is a common condition resulting in reduced quality of life, syncope, and pacemaker (PPM) implantation, but predictors have not been elucidated.

Atrial Flutter 40

Atrial Flutter Quality of Life Pacemaker Arrhythmia 40

Frontiers in Cardiovascular Medicine

JULY 31, 2024

Atrial fibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications. It is a common cause of hospital admissions, significantly impacts quality of life, increases morbidity and decreases life expectancy.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Diet Arrhythmia 52

Cardiology Update

JANUARY 12, 2025

Hashtag: #ACC25 European Heart Rhythm Association (EHRA) Congress 2025 Date: 30 March to 1 April 2025 Location: Vienna and online Overview: The yearly gathering of the European Heart Rhythm Association (EHRA) unites scientists, healthcare professionals, and other stakeholders engaged in the global management of arrhythmias.

Heart Failure 52

Heart Failure Atherosclerosis Heart Rhythm Nursing 52

HeartRhythm

SEPTEMBER 16, 2024

Implantable cardioverter-defibrillators (ICDs) are established as the standard of care for patients who are deemed at increased risk of life-threatening ventricular arrhythmias. It may lead to decreased frequency, avoidance, and even long-term abstinence from sexual activity, thereby reducing perceived quality of life.

Defibrillator 40

Defibrillator Quality of Life Arrhythmia 40

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 3, 2023

Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012043, November 1, 2023. Prospectively defined secondary end points included repeat ablations, unscheduled arrhythmia-related visits, and quality of life among groups.RESULTS:Of 200 PersAF patients, 98 were assigned to ADT OFF and 102 to ADT ON.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Quality of Life Ablation 40

International Journal of Cardiovascular Sciences

SEPTEMBER 13, 2023

The disease can cause a variety of symptoms, including heart failure, arrhythmias, peripheral embolism, dysautonomia, angina with normal coronary arteries, and others. The aim of this thematic collection is to gather high-quality articles that contribute to the advancement of knowledge about cardiac amyloidosis.

Article 52

Article Angina Quality of Life Embolism 52

Circulation: Cardiovascular Interventions

FEBRUARY 10, 2025

Hypertrophic cardiomyopathy is a common but underrecognized cardiac disorder characterized by a heterogenous phenotype that includes increased left ventricular thickness, outflow obstruction, diastolic dysfunction, and arrhythmia. Hypertrophic cardiomyopathy is often heritable and associated with pathogenic variants in sarcomeric genes.

Cardiomyopathy 40

Cardiomyopathy Quality of Life Bicuspid/Mitral Cardiovascular Interventions 40

HeartRhythm

APRIL 7, 2024

Atrial fibrillation (AF), already the most prevalent clinical arrhythmia, is increasing in prevalence1. It is associated with adverse outcomes that significantly impact the quality of life (QoL) experienced by patients. Thus, the accurate evaluation of QoL is an emerging part of the assessment of AF patients2.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Outcomes Arrhythmia 40

DAIC

JUNE 11, 2024

PFA is designed to address AFib, the most common arrhythmia in the US, with a growing patient population. Another Farapulse PFA study looked at the post-ablation atrial arrhythmia (AA) burden associated with PFA and found less AA burden and improved quality of life in the study population.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

DAIC

MARCH 12, 2025

This innovative approach not only addresses that need but also improves patient outcomes, ensuring a better quality of life for those diagnosed with A-Fib. He is an expert in the treatment of arrhythmias and is committed to advancing cardiovascular care and improving the lives of patients in Broward County and beyond.

Ablation 52

Ablation Innovation Quality of Life Atrial Fibrillation 52

Cardiology Update

JANUARY 2, 2024

European Heart Rhythm Association (EHRA) Congress Date: April 7-9, 2024 Location: Berlin, Germany and online Overview: The yearly gathering of the European Heart Rhythm Association (EHRA) unites scientists, healthcare professionals, and other stakeholders engaged in the global management of arrhythmias.

Heart Failure 111

Heart Failure Atherosclerosis Cardiovascular Imaging Non-Invasive Cardiology 111

The British Journal of Cardiology

AUGUST 21, 2024

However, due to concerns about arrhythmia and toxicity, its use has declined dramatically over recent decades. It is the only drug that combines an inotropic effect with a reduction in ventricular rate in AF. Therefore, in theory it should be an ideal treatment for HF, especially when there is co-existent AF.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Preserved Ejection Fraction Quality of Life 40

Cardiometabolic Health Congress

AUGUST 30, 2024

Arrhythmias : A leadless pacemaker-defibrillator system provides antitachycardia pacing for ventricular tachycardia in patients with subcutaneous ICDs. Overcoming status quo bias and embracing the latest evidence-based practices are essential steps toward delivering high-quality, personalized care in cardiometabolic medicine.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Heart Failure Quality of Life Aortic 52

MIBHS

SEPTEMBER 15, 2023

This reduced recovery period can lead to a higher quality of life and less disruption to the patient’s routine. Lower Risk of Complications Minimally invasive cardiac surgery has a lower risk of complications such as wound infections, arrhythmias, and respiratory problems when compared to open-heart surgery.

Open-Heart Surgery 52

Open-Heart Surgery Coronary Artery Bypass Graft Cardiovascular Disease Innovation 52

MIBHS

NOVEMBER 30, 2023

While it’s well-known that mental health issues like anxiety and depression can profoundly impact one’s quality of life, what’s often overlooked is their potential to affect physical health, particularly the heart. People with anxiety often experience elevated heart rates and increased blood pressure.

Blood Pressure 52

Blood Pressure Heart Disease Blood Clot Physiology 52

DAIC

DECEMBER 19, 2023

OSA is commonly seen in patients with arrhythmias like atrial fibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. FACC, FHRS, FHSC , Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David's Medical Center.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

GEMMS

MAY 22, 2024

Implantable Devices Implantable cardiac devices, such as pacemakers and implantable cardioverter-defibrillators (ICDs), are crucial in managing arrhythmias and other cardiac conditions. It ultimately aims to improve outcomes and enhance the quality of life for individuals with heart-related conditions.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

MAY 18, 2024

Atrial fibrillation is the most common type of arrhythmia, and by 2050, up to 16 million Americans are projected to have AF 1. Participants also saw a significant improvement in quality of life and reduced healthcare utilizations in terms of cardiovascular hospitalizations, cardioversion, and antiarrhythmic drug use.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

Open Heart

JANUARY 17, 2024

The primary endpoint of this study was a composite of major adverse cardiovascular events (MACEs), including all-cause death, acute coronary syndromes, heart failure events, ischaemic strokes, sustained ventricular arrhythmias and acute kidney injury at 1-year follow-up.

Myocardial Infarction 96

Myocardial Infarction Quality of Life Heart Failure Stroke 96

DAIC

APRIL 9, 2024

It is also published in Heart Rhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS. Antiarrhythmic drugs are advised for some patients to prevent arrhythmia recurrences early after the procedure.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

DAIC

SEPTEMBER 5, 2024

For more than 40 years, traditional transvenous implantable cardioverter-defibrillators (ICDs) have been saving lives by delivering lifesaving shocks or painless pacing to stop life-threatening fast or irregular heartbeats.

Defibrillator 52

Defibrillator Sudden Cardiac Death Quality of Life Tachycardia 52

European Journal of Heart Failure

NOVEMBER 11, 2024

The main secondary study endpoints are all-cause mortality, cardiovascular mortality, incidence of implantable cardioverter-defibrillator (ICD) therapy, hospitalizations, quality of life, time to first ICD therapy, number of device-detected ventricular tachycardia/ventricular fibrillation episodes, left ventricular function, and exercise tolerance.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Ablation 40

Wellnest

DECEMBER 11, 2023

Prevention of Opportunistic Infections: Reduced Opportunistic Infections: ART significantly lowers the risk of opportunistic infections, such as pneumonia, tuberculosis, and fungal infections, which can be life-threatening in individuals with compromised immune systems. ECGs can identify these abnormalities, enabling timely intervention.

Quality of Life 52

Quality of Life Myocardial Infarction Public Health Arrhythmia 52

ADN Center of Excellence

SEPTEMBER 28, 2023

Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects. Innovative Medications : The development of novel medications has expanded treatment options for heart conditions, improving patients' quality of life.

COVID-19 52

COVID-19 Heart Disease Education Interventional Cardiology 52

Cardiometabolic Health Congress

AUGUST 8, 2024

Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life. This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. Here are four key strategies to achieve this: 1.Shared

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Circulation

NOVEMBER 21, 2024

This American Heart Association scientific statement provides an update on the current state of knowledge of the pathophysiology, methods of surveillance, risk stratification, and latest available therapies, including transcatheter and surgical pulmonary valve replacement strategies, as well as management of life-threatening arrhythmias.

Quality of Life 81

Quality of Life Pulmonary Stenosis Arrhythmia 81

Circulation: Arrhythmia and Electrophysiology

DECEMBER 19, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Patients with atrial fibrillation (AF) are often ill-equipped for shared decision-making.

Nursing 40

Nursing Atrial Fibrillation Quality of Life Electrophysiology 40